The Current Ratio as of December 2025 (TTM) for Inhibitor Therapeutics, Inc. (INTI) is 35.00

According to Inhibitor Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 35.00. This represents a change of 19.60% compared to the average of 29.27 of the last 4 quarters.

Inhibitor Therapeutics, Inc. (INTI) Historical Current Ratio (quarterly & annually)

How has INTI Current Ratio performed in the past?

The mean historical Current Ratio of Inhibitor Therapeutics, Inc. over the last ten years is 6.89. The current 35.00 Current Ratio has changed 50.72% with respect to the historical average. Over the past ten years (40 quarters), INTI's Current Ratio was at its highest in in the June 2023 quarter at 231.61. The Current Ratio was at its lowest in in the June 2022 quarter at 0.04.

Inhibitor Therapeutics, Inc. (INTI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Inhibitor Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inhibitor Therapeutics, Inc. (INTI) Average Current Ratio

How has INTI Current Ratio performed in the past?

The current Current Ratio of Inhibitor Therapeutics, Inc. (INTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Inhibitor Therapeutics, Inc. (INTI) Current Ratio vs. Peers

How is INTI’s Current Ratio compared to its peers?

Inhibitor Therapeutics, Inc.’s Current Ratio is less than LianBio (74.19), greater than Oxford BioDynamics Plc (2.59), greater than Devonian Health Group Inc. (1.12), greater than Chimeric Therapeutics Limited (0.72), greater than Quantum Genomics S.A. (2.73), greater than Curative Biotechnology, Inc. (0.05), greater than Nymox Pharmaceutical Corporation (0.09), greater than BetterLife Pharma Inc. (0.04), greater than PharmaTher Holdings Ltd. (3.11), greater than Nass Valley Gateway Ltd. (0.00),

Build a custom stock screener for Inhibitor Therapeutics, Inc. (INTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inhibitor Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inhibitor Therapeutics, Inc. (INTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inhibitor Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.